A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol
Condition: Langerhans Cell Histiocytosis Interventions: Drug: Prednisone+Cytarabine+vincristine; Drug: Prednisone+Cytarabine+vincristine+Mercaptopurine; Drug: Prednisone+vincristine+Mercaptopurine; Drug: Prednisone+vincristine; Other: Local therapy Sponsor: Shanghai Children's Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials